SSSameer Sharma

Sameer Sharma

*This is an algorithmically generated author record based on publicly available information.

Sameer Sharma has a total of 97 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Prognostic implications of TIMP1 gene expression in colon Adenocarcinoma: structural and functional consequences of non-synonymous SNP variants

    by Dinesh Sosalagere Manjegowda, Keerthana Shyam, Akitha M.K Devi, Susha Dinesh, Sameer Sharma, Ajay Kumar Kataria, Akanksha Kulshreshtha, Ratul Bhowmik, Ashok Aspatwar

    The investigation into single nucleotide polymorphism (SNP) mutations within the TIMP1 gene, particularly in the context of colon cancer, is a topic of considerable scientific research. Numerous studies emphasize the pivotal role of TIMP1 in the promotion of tumorigenesis and metastasis in human colon cancer, positioning it as a potential prognostic marker and therapeutic target. Identifying polymorphisms influencing the structure and function of the TIMP1 gene is crucial. In this study, we pinpointed damaging non-synonymous SNPs (nsSNPs) among 2130 SNPs, with rs192373432 (R192W), rs145224385 (R203W), and rs199775125 (T171M) identified as deleterious, probably damaging, and exposed, respectively. Notably, the R203W substitution demonstrated the highest destabilizing effect (DDG value: -0.92872 Kcal/mol), indicating a more significant impact on protein stability than the other variants (R192W: -0.20284 Kcal/mol, T171M: -0.07699 Kcal/mol). Molecular dynamics simulations revealed that the R192W mutation results in a more rigid, compact, and structurally stable protein with reduced flexibility and fewer hydrogen bonds compared to the wild type, which might affect its functional interactions and stability. The 2D projection of the trajectory indicated that the mutant occupies a more constrained conformational space, reinforcing its rigid nature. The protein interaction network revealed associations with extracellular matrix remodeling (MMP1, MMP2, MMP3, MMP9, MMP10), inflammation (IL6, IL10), and immune response (CD63, FN1), offering insights into TIMP1’s potential mechanisms in colon cancer and identifying new therapeutic targets. Analysis of TIMP1 gene expression and survival in Colon Adenocarcinoma (COAD) unveiled a dual association, where both overexpression and downregulation of TIMP1 correlated with patient survival. Further research is essential to comprehensively understand the regulatory role of these genes on TIMP1 and their impact on colon cancer development and progression.

  • Computational Screening of Clinical Drug Libraries for Neurofibromin Inhibition: A Molecular Docking and Dynamics Study for Neurofibromatosis Therapy

    by Esha Patel, Ajay Nair, Sameer Sharma, Diya Bhalla, Keerthana Shyam, Susha Dinesh

    Introduction: Neurofibromatosis type 1 (NF1) is a genetic disorder characterized by the development of benign tumors due to mutations in the NF1 gene, which encodes the tumor suppressor neurofibromin. This study aimed to identify novel inhibitors of neurofibromin through drug repurposing of clinical trial compounds from the Zinc15 database. Method: Utilizing advanced in silico techniques, we conducted molecular docking via PyRx and molecular dynamics simulations with GROMACS. Among the compounds analyzed, ZINC000261527152 (Tetrodotoxin) emerged as a promising candidate due to its binding affinity to NF1. Tetrodotoxin formed stable conventional and carbon-hydrogen bonds with key residues, including GLU 981, GLY 984, GLN 985, SER 1030, SER 1561, and ASN 1563. Molecular dynamics simulations confirmed the stability of the Tetrodotoxin- NF1 complex, with favorable RMSD, RMSF, radius of gyration (Rg), and solvent- accessible surface area (SASA) values over a 100 ns simulation period. Result: These results suggest that Tetrodotoxin could effectively inhibit neurofibromin, presenting a novel therapeutic approach for neurofibromatosis. However, despite the promising computational findings, further experimental validation through in vitro and in vivo studies is essential to confirm the efficacy and safety of Tetrodotoxin as a treatment for NF1. Conclusion: This research underscores the utility of computational drug repurposing methodologies and their role in accelerating the discovery of novel treatments for genetic disorders, particularly neurofibromatosis, thereby potentially improving patient outcomes and quality of life.


  • Exploration of novel phytochemicals as α-synuclein aggregation inhibitors in the context of Parkinson’s disease therapy: an in-silico approach

    by Garima Gupta, Deepika Joshi, Gopeshwar Narayan, Sameer Sharma

    The misfolding and aggregation of alpha-synuclein play a pivotal role in the pathogenesis of Parkinson’s disease (PD), contributing to neuronal dysfunction, the formation of Lewy bodies, and the manifestation of motor symptoms characteristic of PD. Understanding these molecular mechanisms is imperative for advancing therapeutic strategies for this neurodegenerative disorder. Current treatment modalities primarily involve dopamine replacement drugs, which fail to halt or slow disease progression. This study employs in-silico methods, including molecular docking and molecular dynamics simulations, to comprehensively evaluate naturally derived phytochemicals (n = 875) with neuroprotective or therapeutic potential in PD. Among these compounds, Crebanine exhibited the least binding energy at 13.7 kcal/mol, while Alpinetin showed − 3.2 kcal/mol. The RMSD values remained consistent after approximately 60 ns and 40 ns for Crebanine and Alpinetin, respectively, indicating stable predicted models. These findings underscore the potential of phytocompounds as candidates for PD therapeutics and warrant further in vitro and in vivo investigations to validate their efficacy. This approach represents a promising avenue for developing novel treatments that target the underlying molecular mechanisms of PD.


  • Top Cited Papers
    Open Access

    Inside the impulsive brain: a narrative review on the role of neurobiological, hormonal and genetic factors influencing impulsivity in psychiatric disorders

    by Hannah Raji, Susha Dinesh, Sameer Sharma

    This abstract delves into the intricate nature of impulsivity and its ramifications across psychiatric disorders, leveraging advancements in neuroimaging and psychological studies. It elucidates diverse facets of impulsivity, encompassing response, choice, and tendencies, emphasizing its pivotal role in executive functioning and social development. The intricate interplay of hormonal influences, specifically cortisol, adrenaline, and testosterone, is meticulously examined, unveiling associations between elevated cortisol levels, excessive adrenaline release, and heightened impulsivity. The ventromedial prefrontal cortex (VMPFC) assumes a central role in decision-making and emotional regulation, demonstrating correlations with conditions, such as antisocial behavior and mood disorders. Substantial contributions from neurotransmitters like dopamine and serotonin to impulsive behavior underscore the imperative need for genetic and neurochemical investigations to identify factors crucial for effective management. Interconnections between stress, impulsivity, and decision-making are accentuated, particularly in mood disorders. Hormones, such as leptin and ghrelin, in conjunction with the hypothalamic–pituitary–adrenal axis, play pivotal roles in conditions like major depressive disorder. Concurrently, leptin resistance exerts influence over appetite and mood regulation. The nexus between impulsivity and substance use disorders emphasizes the intricate involvement of neurobiological, neurotransmitter, and genetic components, guiding targeted interventions. Recognition of gender-specific impulsive behaviors and hormonal influences is imperative for tailoring treatment plans. Advocating a comprehensive approach that integrates hormonal assessments with clinical evaluations, taking into account the neurobiological context, is essential. While serotonin systems show promise for treating impulsive aggressiveness, challenges encompass intricate hormonal interactions, ethical considerations, limited treatment options, and the necessity for individualized approaches. Addressing these intricacies is pivotal for advancing knowledge and formulating effective interventions for Impulsive Control Disorders.


  • Comparative proteomic analysis to annotate the structural association of the hypothetical proteins from the conserved domain of P. aeruginosa as novel vaccine candidates

    by Prajval Tenginakai, Samiksha Bhor, Fathimathuz Zehra Waasia, Sameer Sharma, Susha Dinesh

    Objectives Pseudomonas aeruginosa, identified as an ESKAPE pathogen, contributes to severe clinical diseases worldwide and despite its prevalence an effective vaccine or treatment remains elusive. Numerous computational methods are being employed to target hypothetical proteins (HPs). Presently, no studies have predicted multi-epitope vaccines for these HPs. Results Totally, 877 HPs from P. aeruginosa were included in the study and the data showcased here illustrate a methodical approach to prioritize the proteome by employing diverse comparative proteomics. The study employed physicochemical property assessment and conserved domain analysis to identify stable and immunologically pertinent proteins for epitope prediction. The VaxiJen2.0 antigenicity assessment aided in epitope selection, contributing to the foundational steps in vaccine development by predicting T-cell and B-cell epitopes. Potential T and B cell epitopes with high antigenicity, non-toxic categorization, and robust binding affinities were identified in the investigation. The periplasmic HP WP_132813935.1 was predicted as conserved, stable, and soluble. The T-cell peptide RTSMRALAY and the B-cell peptide MPVYLYLM were predicted to be probable non-allergen and demonstrated strong binding with MHC class I allele HLA-C*03:03. Conclusions This research provides a comprehensive approach to predict T and B cell epitopes for conditions associated with P. aeruginosa, offering a candidate pool for tailored vaccine development. However, the efficacy of these epitopes in vaccine development necessitates clinical validation and testing for confirmation.


  • Computational Identification and Functional Analysis of Potentially Pathogenic nsSNPs in the NLRP3 Gene Linked to Alzheimer’s Disease

    by Alya Redhwan, Mohd Adnan, Hadeel R. Bakhsh, Nawaf Alshammari, Malvi Surti, Mansi Parashar, Mirav Patel, Mitesh Patel, Dinesh Sosalagere Manjegowda, Sameer Sharma


  • Open Access

    APV9WR: An Integrated Web Resource of Alpha papillomavirus 9 for Genomics, Proteomics, Phylogenetic and Therapeutic Analysis

    by Akanksha Kulshreshtha, Vasu Goel, Akriti Verma, Sparsh Goel, Susha Dinesh, Sameer Sharma, Ratul Bhowmik, Ashok Aspatwar

    Purpose: Alphapapillomavirus 9 is a virus belonging to the Papillomaviridae family. It has a close genetic relationship with high-risk HPV-16 and other HPV strains such as HPV-31, HPV-52, HPV-35, HPV-58, HPV-67, and HPV-35. This virus is responsible for causing warts and malignant tumors and is responsible for about 75% of cervical malignancies and pre-cancerous lesions worldwide. As a result, it requires specialized research and attention. Our goal is to create a comprehensive resource that can assist researchers and scientific groups in their work. Material and Methodology: A total of 1230 full genome sequences and 9140 protein sequences were obtained from GenBank and NCBI Virus, respectively. Further Phylogenetic Analysis, Codon usage and context analysis, CpG islands analysis, Glycosylation sites, Diagnostic Primers, B cell Epitopes and MHC I and MHC II binders were identified and analyzed using relevant Bioinformatics tools and Python program Results: APV9WR is a web resource that was developed after analysis. Our data indicate that HPV 35 and HPV 38 have the most genomic diversity. From codon usage analysis, it was observed that AAA, AUU, UAU, UGU, and UUU are the most used codons, while ACG, CCG, CGA, CGG, CGU, GCG, and UCG are some of the unusual codons in APV9 nucleotide sequence with accession id - LC626346.1 . We found 4714 CpG island locations in 1230 complete nucleotide sequences of APV9, and only 663 CpG island locations were unique. Further N-linked glycosylation, O-linked glycosylation, diagnostic primers, Potential B-cell epitopes and MHC I and MHC II binders were also analyzed and tabulated. Conclusion: We have consolidated basic information about the virus, such as entire genomic sequences and proteins. It primarily comprises a wide range of studies and outcomes, including genome alignment, phylogenetic inferences, codon context and usage bias, and important CpG island statistics. Furthermore, primers for molecular diagnostics were identified, and glycosylation sites were located and investigated. Most significantly, potential therapeutic elements such as vaccine epitopes and obtaining potential information about them were investigated. Our collective effort on this tool is meant to serve the greater good of the research community for therapeutic intervention for Alphapapillomavirus 9. Using this link https://apv9nsut.web.app will take you to the web app.

  • Open Access

    Elucidating Molecular Mechanism and Chemical Space of Chalcones through Knowledge Graph and Machine Learning: A Combined Bio-Cheminformatic Pipeline

    by Ajay Manaithiya, Ratul Bhowmik, Satarupa Acharjee, Sameer Sharma, Sunil Kumar, Mohd. Imran, Bijo Mathew, Seppo Parkkila, Ashok Aspatwar

    We developed a bio-cheminformatics method, exploring disease inhibition mechanisms using machine learning-enhanced quantitative structure-activity relationship (ML-QSAR) models and knowledge-driven neural networks. ML-QSAR models were developed using molecular fingerprint descriptors and the Random Forest algorithm to explore the chemical spaces of Chalcones inhibitors against diverse disease properties, including antifungal, anti-inflammatory, anticancer, antimicrobial, and antiviral effects. We generated and validated robust machine learning-based bioactivity prediction models (( https://ashspred.streamlit.app/ ) for the top genes. These models underwent ROC and applicability domain analysis, followed by molecular docking studies to elucidate the molecular mechanisms of the molecules. Through comprehensive neural network analysis, crucial genes such as AKT1, HSP90A1, SRC, and STAT3 were identified. The PubChem fingerprint-based model revealed key descriptors: PubchemFP521 for AKT1, PubchemFP180 for SRC, PubchemFP633 for HSP90, and PubchemFP145 and PubchemFP338 for STAT3, consistently contributing to bioactivity across targets. Notably, chalcone derivatives demonstrated significant bioactivity against target genes, with compound RA1 displaying a predictive pIC 50 value of 5.76 against HSP90A and strong binding affinities across other targets. Compounds RA5 to RA7 also exhibited high binding affinity scores comparable to or exceeding existing drugs. These findings emphasize the importance of knowledge-based neural network-based research for developing effective drugs against diverse disease properties. These interactions warrant further in vitro and in vivo investigations to elucidate their potential in rational drug design. The presented models provide valuable insights for inhibitor design and hold promise for drug development. Future research will prioritize investigating these molecules for mycobacterium tuberculosis , enhancing the comprehension of effectiveness in addressing infectious diseases.


  • Open Access

    WITHDRAWN: Molecular Insights into Zea mays Active Phytochemicals for Diabetes and Inflammation Treatment: A Web App-Based Machine Learning and Network Pharmacology Approach

    by Ajay Manaithiya, Ratul Bhowmik, Ahmed A. Elhenawy, Sameer Sharma, Susha Dinesh, Seppo Parkkila, Ashok Aspatwar

    Traditional medicinal plants such as Zea mays show promising activities against diabetes and inflammation, yet their underlying molecular mechanisms remain elusive. Nevertheless, further elucidation of the molecular mechanism by which this medicinal plant exerts its anti-diabetic and anti-inflammatory effects and the relationship between its active constituents’ structure and activity is needed. Using a polypharmacology approach, this study identified metabolic pathways targeted by active phytochemicals of the medicinal plant Zea mays. Extensive network pharmacology and systems biology approaches, including protein-protein interaction network analysis, Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analysis, and gene functional enrichment studies, revealed that AKT1 is the key gene involved in the molecular mechanism of active phytochemicals involved in their antidiabetic and anti-inflammatory effects. A robust machine-learning-guided bioactivity prediction model-based web application (https://akt1-pred.streamlit.app/) against AKT1 was developed by implementing PubChem and substructure fingerprint molecular signatures. Further validation was performed by conducting ROC and applicability domain analysis, with subsequent molecular docking studies to understand the molecular mechanisms of the phytochemicals. The web application (Akt1-pred) predicted that delta-tocopherol, thiamine, and 9-ribosyl-trans-zeatin were the most active phytochemicals responsible for the antidiabetic and anti-inflammatory effects of the medicinal plant Zea mays, which was further supported by extensive molecular docking analysis and molecular dynamics simulation studies. These findings indicate a correlation between the structure of these molecules and their bioactivity, with some phytochemicals performing comparably or better than known FDA drugs. The results show that natural products could be very useful for medicine. They encourage more lab and animal studies and lay a strong base for future research on how these natural products can lead to new drugs.


  • From Gut to Glucose: A Comprehensive Review on Functional Foods and Dietary Interventions for Diabetes Management

    by Nirali Patel, Susha Dinesh, Sameer Sharma

    Background:: In the realm of diabetes research, considerable attention has been directed toward elucidating the intricate interplay between the gastrointestinal tract and glucose regulation. The gastrointestinal tract, once exclusively considered for its role in digestion and nutrient assimilation, is presently acknowledged as a multifaceted ecosystem with regulatory supremacy over metabolic homeostasis and glucose metabolism. Recent studies indicate that alterations in the composition and functionality of the gut microbiota could potentially influence the regulation of glucose levels and glucose homeostasis in the body. Dysbiosis, characterized by perturbations in the equilibrium of gut microbial constituents, has been irrevocably linked to an augmented risk of diabetes mellitus (DM). Moreover, research has revealed the potential influence of the gut microbiota on important factors, like inflammation and insulin sensitivity, which are key contributors to the onset and progression of diabetes. The key protagonists implicated in the regulation of glucose encompass the gut bacteria, gut barrier integrity, and the gut-brain axis. A viable approach to enhance glycemic control while concurrently mitigating the burden of comorbidities associated with diabetes resides in the strategic manipulation of the gut environment through adapted dietary practices. Objective:: This review aimed to provide a deep understanding of the complex relationship between gut health, glucose metabolism, and diabetes treatment. Conclusion:: This study has presented an exhaustive overview of dietary therapies and functional foods that have undergone extensive research to explore their potential advantages in the management of diabetes. It looks into the role of gut health in glucose regulation, discusses the impact of different dietary elements on the course of diabetes, and evaluates how well functional foods can help with glycemic control. Furthermore, it investigates the mechanistic aspects of these therapies, including their influence on insulin sensitivity, β-cell activity, and inflammation. It deliberates on the limitations and potential prospects associated with integrating functional foods into personalized approaches to diabetes care.